INM

INMED PHARMACEUTICALS INC

INM·457637601·UQ·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

INM institutional ownership changes in Q2 2026: 1 institution opened or added positions, 3 trimmed or exited. INM (INMED PHARMACEUTICALS INC) is held by 3 institutional investors as of Q2 2026. Top institutional shareholders: JANE STREET GROUP, LLC ($66,771), CITADEL ADVISORS LLC ($40,430), Federation des caisses Desjardins du Quebec ($4). Net institutional sentiment: Bearish.

3
Holders
$107,205
Total Value
25% (4)
Consensus
1 buying - 3 selling
13F: Insider & Congress: Updated regularly
INM

Smart Money Verdict

View all
Loading verdict
Held by 3 funds

Who's Trading

Source dates: Price Oct 28, 2026 · Insiders Oct 20, 2026 · Activists Apr 2, 2025 · Congress none

InsiderADADAR1 Capital Management, LLCBuy $1KOct 19, 2026
InsiderADADAR1 Capital Management, LLCBuy $1.32Oct 16, 2026
InsiderADADAR1 Capital Management, LLCBuy $1KOct 15, 2026
Checking access…

Top Holders

Checking access…
Action
New
43,078$66,7710.0%+3.17%
32
Decreased
26,084(-44.5%)$40,4300.0%+110.42%
0
Unchanged
2$40.0%-53.71%
0
Exited
0(-100.0%)$13,0000.0%+103.95%
0
Exited
0(-100.0%)$5,2040.0%+99.77%
0
INMINMINMED PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used